Asia’s first combined liver transplant and aortic valve replacement

doi:10.1016/j.hbpd.2018.01.011

Abstract
Figure/Table
References (0)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract To the editor:
Liver transplantation is the only cure for patients with endstage liver disease. It is however an ultra-major surgery which is physiologically challenging to the cardiopulmonary function of the patients. Hence, in patients who also have valvular heart disease or coronary artery disease, liver transplantation would be considered to be contraindicated unless their cardiac problems could be corrected. On the other hand, coagulopathy and the risk of postoperative liver decompensation associated with end-stage liver disease would render the patients unsuitable for corrective valve repair or coronary artery bypass graft surgery. In the literature, there are only a small number of cases of combined liver transplantation and cardiac surgery.

Key words： Liver transplantation Aortic valve replacement

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles in this journal by
	Cheung CY
	Chok KSH
	Lee OJ
	Lo KS
	Chan SC
	Lo CM

Cite this article:

Cheung CY, Chok KSH, Lee OJ, et al. Asia’s first combined liver transplant and aortic valve replacement. Hepatobiliary Pancreat Dis Int 2018; 17(1): 86-87. DOI:10.1016/j.hbpd.2018.01.011

URL:

http://dx.doi.org/10.1016/j.hbpd.2018.01.011 OR http://www.hbpdint.com/EN/Y2018/V17/I1/86